Agra Ventures Provides Farmako-Related Update on German Legalization of Recreational Cannabis - Seite 2

For interested readers, the Article can be found here: https://ca.internationalcbc.com/prohibition-treaties-will-not-stop-can ....

Management Commentary

“An article like this shows that Germany – taking into account the challenges and experiences from other countries – will now take a very important role in establishing an effective framework for legalization to likely become a role model for other European and international countries. I believe that the legalization of recreational cannabis in Germany is a near-term reality, which I expect will create material value for AGRA and its stakeholders, despite some efforts to delay it. While German cannabis industry is picking up steam, education and regulation are keeping users safe, which is important to us here at Farmako,” said Katrin Eckmans, Managing Director and CEO of Farmako GmbH.

About Farmako

Farmako GmbH is a GDP certified pharmaceutical wholesaler, focusing on medical cannabis and aiming at facilitating access to reliable cannabinoid therapy to patients with a high burden of suffering as well as providing efficient support to healthcare professionals: via fair prices, reliable product quality and the ability to supply as well as efficient service. It has already distributed medical cannabis to pharmacies in Germany since March 2019 and is fully licensed in the United Kingdom. Farmako is a wholly owned subsidiary of Agra Ventures Ltd. For more information please visit: www.farmako.de/en/.

About Agra Ventures Ltd.

Agra Ventures is a growth-oriented and diversified company focused on the international cannabis industry. The company is dedicated to the cultivation, distribution and marketing of high-quality cannabis and cannabis-infused products worldwide. Agra Ventures’ primary asset in Canada is Boundary Bay Cannabis located in Delta, BC, which is one of the largest cannabis greenhouse facilities focused on the cost-optimized cultivation of high-potency cannabis. Abroad, the company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom.